D-STAT FLOWABLE HEMOSTAT 4000 NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2005-05-02 for D-STAT FLOWABLE HEMOSTAT 4000 NA manufactured by Vascular Solutions, Inc..

Event Text Entries

[368681] A physician has reported several instances of pain, increase in heart rate, and "altered states of consciousness" following use of the d-stat flowable hemostat during liver and kidney biopsies. No specific patient information is available. The d-stat flowable hemostat is not indicated for use during or after liver or kidney biopsies.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2134812-2005-00451
MDR Report Key597846
Report Source05,07
Date Received2005-05-02
Date of Report2005-05-02
Date Mfgr Received2005-04-06
Date Added to Maude2005-05-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactLINDA BUSKLEIN
Manufacturer Street6464 SYCAMORE COURT
Manufacturer CityMINNEAPOLIS MN 55369
Manufacturer CountryUS
Manufacturer Postal55369
Manufacturer Phone7636565300
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameD-STAT FLOWABLE HEMOSTAT
Generic NameTOPCIAL HEMOSTAT
Product CodeMHW
Date Received2005-05-02
Model Number4000
Catalog NumberNA
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key587679
ManufacturerVASCULAR SOLUTIONS, INC.
Manufacturer Address* MINNEAPOLIS MN * US
Baseline Brand NameD-STAT FLOWABLE HEMOSTAT
Baseline Generic NameTOPICAL HEMOSTAT
Baseline Model No4000
Baseline Catalog NoNA
Baseline IDNA
Baseline Device FamilyNA
Baseline Shelf Life Contained*
Baseline Shelf Life [Months]12
Baseline PMA FlagY
Premarket ApprovalP9900
Baseline 510K PMNY
Premarket NotificationK012293
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2005-05-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.